Daily chlorhexidine bathing in ICU reduces infections

In this large randomized trial of ICU patients, they were randomized to daily bathing with or without chlorhexidine; those in the chlorhexidine group had a 23% lower risk of the acquisition of any MDROs, and 28% lower risk of hospital acquired bloodstream infections during their hospital stay. This should become the standard of care for all ICU patients (abstract).

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment